MESA LABORATORIES INC /CO (MLAB) Spending and interest coverage
- R&D / revenue · 12 months: Value 8.03%; Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 6.55%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 8.03% | Research and development expense / revenue. Period ending 2026-06-30. $20.05M ÷ $249.72M × 100 ≈ 8.03% |
| Stock-based compensation / revenue · 12 months | 6.55% | Share-based compensation / revenue. Period ending 2026-06-30. $16.35M ÷ $249.72M × 100 ≈ 6.55% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 20.05M USD | Research and Development Expense |
| Revenue | 249.72M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 16.35M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 22.48M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $20.05M | $249.72M | $16.35M | $22.48M | (m) | 8.03% | 6.55% | (m) | (m) |
| 2026-03-31 | $20.31M | $249.13M | $17.87M | $18.51M | (m) | 8.15% | 7.17% | (m) | (m) |
| 2025-12-31 | $20.16M | $247.54M | $14.21M | $17.23M | (m) | 8.14% | 5.74% | (m) | (m) |
| 2025-09-30 | $20.18M | $245.25M | $14.07M | $15.04M | (m) | 8.23% | 5.74% | (m) | (m) |
| 2025-06-30 | $19.77M | $242.35M | $14.10M | $13.82M | (m) | 8.16% | 5.82% | (m) | (m) |
| 2025-03-31 | $19.52M | $240.98M | $13.14M | $16.34M | (m) | 8.10% | 5.45% | (m) | (m) |
| 2024-12-31 | $19.62M | $237.75M | $12.80M | $-256.42M | (m) | 8.25% | 5.38% | (m) | (m) |
| 2024-09-30 | $18.86M | $228.38M | $12.55M | $-262.26M | (m) | 8.26% | 5.50% | (m) | (m) |
| 2024-06-30 | $19.22M | $223.71M | $11.90M | $-265.83M | (m) | 8.59% | 5.32% | (m) | (m) |
| 2024-03-31 | $19.30M | $216.19M | $11.94M | $-272.07M | $5.70M | 8.93% | 5.52% | -47.76× | Reported |
| 2023-12-31 | $19.10M | $212.87M | $11.82M | $-274.00K | $5.19M | 8.97% | 5.55% | -0.05× | Reported |
| 2023-09-30 | $19.61M | $213.69M | $10.89M | $3.19M | $4.50M | 9.17% | 5.09% | 0.71× | Reported |
| 2023-06-30 | $19.60M | $219.27M | $12.07M | $7.25M | $4.80M | 8.94% | 5.51% | 1.51× | Reported |
| 2023-03-31 | $20.49M | $219.08M | $12.54M | $3.32M | $4.77M | 9.35% | 5.72% | 0.70× | Reported |
| 2022-12-31 | $20.66M | $222.37M | $13.31M | $2.69M | $4.63M | 9.29% | 5.99% | 0.58× | Reported |
| 2022-09-30 | $21.03M | $222.78M | $14.96M | $-3.22M | $4.48M | 9.44% | 6.71% | -0.72× | Reported |
| 2022-06-30 | $18.66M | $199.87M | $12.63M | $-3.02M | $4.03M | 9.33% | 6.32% | -0.75× | Reported |
| 2022-03-31 | $15.77M | $184.34M | $11.39M | $4.70M | $3.88M | 8.55% | 6.18% | 1.21× | Reported |
| 2021-12-31 | $13.26M | $163.42M | $10.32M | $9.11M | $4.87M | 8.11% | 6.32% | 1.87× | Reported |
| 2021-09-30 | $10.80M | $142.90M | $10.23M | $11.64M | $5.80M | 7.56% | 7.16% | 2.01× | Reported |
| 2021-06-30 | $10.60M | $138.92M | $10.20M | $11.91M | $6.98M | 7.63% | 7.34% | 1.71× | Reported |
| 2021-03-31 | $10.39M | $133.94M | $9.27M | $12.36M | $8.02M | 7.76% | 6.92% | 1.54× | Reported |
| 2020-12-31 | $10.03M | $130.18M | $7.10M | $8.66M | $7.79M | 7.70% | 5.46% | 1.11× | Reported |
| 2020-09-30 | $9.43M | $127.66M | $6.75M | $5.38M | $7.76M | 7.39% | 5.29% | 0.69× | Reported |
| 2020-06-30 | $7.93M | $121.34M | $5.92M | $5.30M | $7.03M | 6.54% | 4.88% | 0.75× | Reported |
| 2020-03-31 | $6.36M | $117.69M | $5.53M | $7.49M | $5.50M | 5.40% | 4.69% | 1.36× | Reported |
| 2019-12-31 | $5.01M | $109.92M | $7.10M | $9.15M | (m) | 4.56% | 6.46% | (m) | (m) |
| 2019-09-30 | $3.76M | $104.95M | $4.53M | $13.86M | (m) | 3.58% | 4.32% | (m) | (m) |
| 2019-06-30 | $3.69M | $104.28M | $4.34M | $10.41M | (m) | 3.54% | 4.16% | (m) | (m) |
| 2019-03-31 | $3.51M | $103.14M | $4.21M | $9.78M | (m) | 3.40% | 4.08% | (m) | (m) |
| 2018-12-31 | $3.29M | (m) | $2.67M | $13.86M | (m) | (m) | (m) | (m) | (m) |
| 2018-09-30 | $3.18M | (m) | $2.42M | $2.46M | (m) | (m) | (m) | (m) | (m) |
| 2018-06-30 | $3.22M | (m) | $1.87M | $4.96M | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | $3.54M | $96.18M | $1.67M | $2.18M | (m) | 3.68% | 1.74% | (m) | (m) |
| 2017-12-31 | $4.01M | $93.60M | $1.61M | $882.00K | (m) | 4.28% | 1.72% | (m) | (m) |
| 2017-09-30 | $4.12M | $93.77M | $1.55M | $15.36M | (m) | 4.39% | 1.66% | (m) | (m) |
| 2017-06-30 | $4.28M | $95.22M | $1.52M | $15.72M | (m) | 4.49% | 1.60% | (m) | (m) |
| 2017-03-31 | $4.16M | $93.67M | $1.41M | $16.31M | (m) | 4.44% | 1.51% | (m) | (m) |
| 2016-12-31 | $3.98M | $94.18M | $1.55M | $16.82M | (m) | 4.23% | 1.64% | (m) | (m) |
| 2016-09-30 | $4.10M | $90.25M | $1.51M | $16.26M | (m) | 4.54% | 1.67% | (m) | (m) |
| 2016-06-30 | $4.04M | $87.61M | $1.43M | $15.26M | (m) | 4.62% | 1.63% | (m) | (m) |
| 2016-03-31 | $3.97M | $84.66M | $1.33M | $16.32M | (m) | 4.69% | 1.57% | (m) | (m) |
| 2015-12-31 | $3.76M | $78.41M | $1.22M | $14.68M | (m) | 4.80% | 1.55% | (m) | (m) |
| 2015-09-30 | $3.62M | $76.32M | $1.13M | $14.56M | (m) | 4.74% | 1.49% | (m) | (m) |
| 2015-06-30 | $3.51M | $73.09M | $1.04M | $16.45M | (m) | 4.80% | 1.42% | (m) | (m) |
| 2015-03-31 | $3.29M | $71.33M | $993.00K | $15.86M | (m) | 4.62% | 1.39% | (m) | (m) |
| 2014-12-31 | $3.14M | $68.48M | $987.00K | $15.08M | (m) | 4.59% | 1.44% | (m) | (m) |
| 2014-09-30 | $2.83M | $63.77M | $999.00K | $14.18M | (m) | 4.44% | 1.57% | (m) | (m) |
| 2014-06-30 | $2.49M | $57.91M | $970.00K | $11.80M | (m) | 4.29% | 1.68% | (m) | (m) |
| 2014-03-31 | $2.32M | $52.72M | $840.00K | $11.79M | (m) | 4.40% | 1.59% | (m) | (m) |
| 2013-12-31 | $2.25M | $49.82M | $844.00K | $12.29M | (m) | 4.52% | 1.69% | (m) | (m) |
| 2013-09-30 | $2.23M | $48.06M | $1.03M | $11.95M | (m) | 4.63% | 2.15% | (m) | (m) |
| 2013-06-30 | $2.22M | $47.09M | $1.11M | $12.93M | (m) | 4.71% | 2.36% | (m) | (m) |
| 2013-03-31 | $2.01M | $46.44M | $1.11M | $13.10M | (m) | 4.33% | 2.39% | (m) | (m) |
| 2012-12-31 | $1.70M | (m) | $1.01M | $12.51M | (m) | (m) | (m) | (m) | (m) |
| 2012-09-30 | $1.54M | (m) | $710.00K | $13.21M | (m) | (m) | (m) | (m) | (m) |
| 2012-06-30 | $1.33M | (m) | $517.00K | $13.00M | (m) | (m) | (m) | (m) | (m) |
| 2012-03-31 | $1.36M | $39.62M | $464.00K | $12.48M | (m) | 3.43% | 1.17% | (m) | (m) |
| 2011-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | $1.44M | $34.23M | $383.00K | $9.86M | (m) | 4.21% | 1.12% | (m) | (m) |
| 2010-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Senseonics Holdings, Inc. (SENS) | United States | $0.546B | -2.74 |
| HURCO COMPANIES INC (HURC) | United States | $0.140B | -20.39 |
| SYPRIS SOLUTIONS INC (SYPR) | United States | $0.040B | -4.94 |
| ClearSign Technologies Corp (CLIR) | United States | $0.024B | -4.54 |
| FOCUS UNIVERSAL INC. (FCUV) | United States | $0.003B | -0.58 |
| Sensata Technologies Holding plc (ST) | $5.976B | 77.15 | |
| Ralliant Corp (RAL) | United States | $7.737B | -6.14 |
| COGNEX CORP (CGNX) | United States | $9.711B | 65.26 |
| Fortive Corp (FTV) | United States | $16.897B | 31.51 |
| MKS INC (MKSI) | United States | $17.440B | 68.37 |